Geron-logo-black-xsmall.png
Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018
September 26, 2018 20:30 ET | Geron Corporation
MENLO PARK, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will host a conference call to provide an update on the imetelstat collaboration with...
Geron-logo-black-xsmall.png
Geron Corporation Reports Second Quarter 2018 Financial Results and Recent Company Events
July 31, 2018 16:07 ET | Geron Corporation
MENLO PARK, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and six months ended June 30, 2018. Second Quarter and Year to...
Constellation Pharmaceuticals Announces Pricing of Initial Public Offering
July 18, 2018 19:56 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (the “Company”)(Nasdaq:CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to...
Geron-logo-black-xsmall.png
Geron to Present at the Needham Healthcare Conference
March 21, 2018 07:30 ET | Geron Corporation
MENLO PARK, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron-logo-black-xsmall.png
Geron Announces Updates to Imetelstat Clinical Development
July 31, 2017 19:00 ET | Geron Corporation
MENLO PARK, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced updates to the clinical development plans for IMerge and IMbark, the ongoing trials of the...
Geron-logo-black-xsmall.png
Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen
April 10, 2017 07:30 ET | Geron Corporation
Both IMerge and IMbark Continue in Lower Risk Myelodysplastic Syndromes and Relapsed or Refractory Myelofibrosis Conference Call Scheduled for 8:00 a.m. EDT Today, April 10 MENLO PARK, Calif.,...
Geron-logo-black-xsmall.png
Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
March 01, 2017 16:05 ET | Geron Corporation
MENLO PARK, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2016 and recent events. ...
Geron-logo-black-xsmall.png
Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting
December 06, 2016 16:01 ET | Geron Corporation
MENLO PARK, Calif., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced four presentations of exploratory preclinical and clinical data related to the imetelstat...
Geron-logo-black-xsmall.png
Geron Corporation Reports Third Quarter 2016 Financial Results and Recent Events
November 03, 2016 16:05 ET | Geron Corporation
MENLO PARK, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2016 and recent events. For...
Geron-logo-black-xsmall.png
Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
September 12, 2016 07:30 ET | Geron Corporation
MENLO PARK, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of...